INNOVIVA INC (INVA) Stock Fundamental Analysis
USA - NASDAQ:INVA - US45781M1018 - Common Stock
19.37 USD
-0.06 (-0.31%)
19.37 USD
0 (0%)
Overall INVA gets a fundamental rating of 6 out of 10. We evaluated INVA against 195 industry peers in the Pharmaceuticals industry. INVA gets an excellent profitability rating and is at the same time showing great financial health properties. INVA is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, INVA could be worth investigating further for value and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year INVA was profitable.
INVA had a positive operating cash flow in the past year.
In the past 5 years INVA has always been profitable.
INVA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
INVA's Return On Assets of 2.90% is amongst the best of the industry. INVA outperforms 85.20% of its industry peers.
With an excellent Return On Equity value of 5.41%, INVA belongs to the best of the industry, outperforming 84.69% of the companies in the same industry.
INVA's Return On Invested Capital of 12.60% is amongst the best of the industry. INVA outperforms 90.31% of its industry peers.
INVA had an Average Return On Invested Capital over the past 3 years of 11.38%. This is below the industry average of 15.28%.
The last Return On Invested Capital (12.60%) for INVA is above the 3 year average (11.38%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.9% | ||
| ROE | 5.41% | ||
| ROIC | 12.6% |
ROA(3y)11.21%
ROA(5y)16.95%
ROE(3y)22.61%
ROE(5y)34.7%
ROIC(3y)11.38%
ROIC(5y)18.16%
1.3 Margins
With an excellent Profit Margin value of 10.44%, INVA belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Profit Margin of INVA has declined.
The Operating Margin of INVA (47.69%) is better than 98.98% of its industry peers.
INVA's Operating Margin has declined in the last couple of years.
INVA's Gross Margin of 86.60% is amongst the best of the industry. INVA outperforms 91.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 47.69% | ||
| PM (TTM) | 10.44% | ||
| GM | 86.6% |
OM growth 3Y-21.38%
OM growth 5Y-13.2%
PM growth 3Y-54.19%
PM growth 5Y-35.9%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), INVA is creating some value.
INVA has less shares outstanding than it did 1 year ago.
INVA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for INVA has been reduced compared to a year ago.
2.2 Solvency
INVA has an Altman-Z score of 2.28. This is not the best score and indicates that INVA is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.28, INVA is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
The Debt to FCF ratio of INVA is 2.29, which is a good value as it means it would take INVA, 2.29 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.29, INVA belongs to the top of the industry, outperforming 92.35% of the companies in the same industry.
A Debt/Equity ratio of 0.36 indicates that INVA is not too dependend on debt financing.
INVA has a Debt to Equity ratio of 0.36. This is comparable to the rest of the industry: INVA outperforms 42.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.29 | ||
| Altman-Z | 2.28 |
ROIC/WACC1.4
WACC8.97%
2.3 Liquidity
INVA has a Current Ratio of 2.64. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
INVA has a Current ratio of 2.64. This is comparable to the rest of the industry: INVA outperforms 49.49% of its industry peers.
INVA has a Quick Ratio of 2.44. This indicates that INVA is financially healthy and has no problem in meeting its short term obligations.
INVA has a Quick ratio (2.44) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.64 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
The earnings per share for INVA have decreased strongly by -81.21% in the last year.
The earnings per share for INVA have been decreasing by -33.21% on average. This is quite bad
The Revenue has grown by 12.01% in the past year. This is quite good.
The Revenue has been growing slightly by 6.57% on average over the past years.
EPS 1Y (TTM)-81.21%
EPS 3Y-52.04%
EPS 5Y-33.21%
EPS Q2Q%240%
Revenue 1Y (TTM)12.01%
Revenue growth 3Y-2.91%
Revenue growth 5Y6.57%
Sales Q2Q%0.39%
3.2 Future
INVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 83.16% yearly.
The Revenue is expected to grow by 12.04% on average over the next years. This is quite good.
EPS Next Y456.53%
EPS Next 2Y242.88%
EPS Next 3Y133.78%
EPS Next 5Y83.16%
Revenue Next Year7.55%
Revenue Next 2Y9.78%
Revenue Next 3Y10.51%
Revenue Next 5Y12.04%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 62.48 indicates a quite expensive valuation of INVA.
Compared to the rest of the industry, the Price/Earnings ratio of INVA indicates a somewhat cheap valuation: INVA is cheaper than 78.06% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of INVA to the average of the S&P500 Index (27.30), we can say INVA is valued expensively.
The Price/Forward Earnings ratio is 8.67, which indicates a very decent valuation of INVA.
Based on the Price/Forward Earnings ratio, INVA is valued cheaply inside the industry as 87.76% of the companies are valued more expensively.
INVA is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.73, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.48 | ||
| Fwd PE | 8.67 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INVA indicates a rather cheap valuation: INVA is cheaper than 98.47% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INVA is valued cheaper than 94.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.22 | ||
| EV/EBITDA | 4.95 |
4.3 Compensation for Growth
INVA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
INVA has a very decent profitability rating, which may justify a higher PE ratio.
INVA's earnings are expected to grow with 133.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y242.88%
EPS Next 3Y133.78%
5. Dividend
5.1 Amount
No dividends for INVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
19.37
-0.06 (-0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners110.68%
Inst Owner Change7.55%
Ins Owners1.06%
Ins Owner Change1.25%
Market Cap1.22B
Analysts84
Price Target41.82 (115.9%)
Short Float %16%
Short Ratio11.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-149.59%
Min EPS beat(2)-350.17%
Max EPS beat(2)50.98%
EPS beat(4)1
Avg EPS beat(4)-105.72%
Min EPS beat(4)-350.17%
Max EPS beat(4)50.98%
EPS beat(8)4
Avg EPS beat(8)-13.41%
EPS beat(12)6
Avg EPS beat(12)-52.11%
EPS beat(16)7
Avg EPS beat(16)-44.13%
Revenue beat(2)2
Avg Revenue beat(2)5.97%
Min Revenue beat(2)5.11%
Max Revenue beat(2)6.82%
Revenue beat(4)4
Avg Revenue beat(4)7.43%
Min Revenue beat(4)3.7%
Max Revenue beat(4)14.09%
Revenue beat(8)7
Avg Revenue beat(8)8.9%
Revenue beat(12)10
Avg Revenue beat(12)4.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.65%
PT rev (3m)-25.45%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)0.52%
EPS NY rev (1m)54.73%
EPS NY rev (3m)54.73%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)3.69%
Revenue NY rev (3m)4.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.48 | ||
| Fwd PE | 8.67 | ||
| P/S | 3.3 | ||
| P/FCF | 6.22 | ||
| P/OCF | 6.08 | ||
| P/B | 1.71 | ||
| P/tB | 2.78 | ||
| EV/EBITDA | 4.95 |
EPS(TTM)0.31
EY1.6%
EPS(NY)2.23
Fwd EY11.53%
FCF(TTM)3.12
FCFY16.08%
OCF(TTM)3.18
OCFY16.43%
SpS5.87
BVpS11.34
TBVpS6.96
PEG (NY)0.14
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.9% | ||
| ROE | 5.41% | ||
| ROCE | 16.24% | ||
| ROIC | 12.6% | ||
| ROICexc | 23.24% | ||
| ROICexgc | 43.77% | ||
| OM | 47.69% | ||
| PM (TTM) | 10.44% | ||
| GM | 86.6% | ||
| FCFM | 53.03% |
ROA(3y)11.21%
ROA(5y)16.95%
ROE(3y)22.61%
ROE(5y)34.7%
ROIC(3y)11.38%
ROIC(5y)18.16%
ROICexc(3y)16.17%
ROICexc(5y)24.46%
ROICexgc(3y)28.95%
ROICexgc(5y)34.96%
ROCE(3y)14.67%
ROCE(5y)23.41%
ROICexcg growth 3Y-8.78%
ROICexcg growth 5Y-15.28%
ROICexc growth 3Y-21.15%
ROICexc growth 5Y-17.48%
OM growth 3Y-21.38%
OM growth 5Y-13.2%
PM growth 3Y-54.19%
PM growth 5Y-35.9%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 2.29 | ||
| Debt/EBITDA | 1.19 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 17.04 | ||
| Cash Conversion | 92.65% | ||
| Profit Quality | 508.02% | ||
| Current Ratio | 2.64 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 2.28 |
F-Score5
WACC8.97%
ROIC/WACC1.4
Cap/Depr(3y)4.13%
Cap/Depr(5y)2.48%
Cap/Sales(3y)0.45%
Cap/Sales(5y)0.27%
Profit Quality(3y)320.3%
Profit Quality(5y)247.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-81.21%
EPS 3Y-52.04%
EPS 5Y-33.21%
EPS Q2Q%240%
EPS Next Y456.53%
EPS Next 2Y242.88%
EPS Next 3Y133.78%
EPS Next 5Y83.16%
Revenue 1Y (TTM)12.01%
Revenue growth 3Y-2.91%
Revenue growth 5Y6.57%
Sales Q2Q%0.39%
Revenue Next Year7.55%
Revenue Next 2Y9.78%
Revenue Next 3Y10.51%
Revenue Next 5Y12.04%
EBIT growth 1Y29.9%
EBIT growth 3Y-23.66%
EBIT growth 5Y-7.5%
EBIT Next Year-6.31%
EBIT Next 3Y-8.15%
EBIT Next 5YN/A
FCF growth 1Y122.11%
FCF growth 3Y-20.27%
FCF growth 5Y-6.46%
OCF growth 1Y126.68%
OCF growth 3Y-19.65%
OCF growth 5Y-6.03%